How to speed up regulatory submission in drug development

Scott Weiss, Vice President, Business Development and Open Innovation, explores digital workflows with an “audit-by-exception” approach which helps speed up regulatory submission by reducing errors and time to compile data. This approach leads to greater transparency and better relationships with regulatory agencies and helps avoid delays to the market.